Pacer Advisors
LOXO

Pacer Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Pacer Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,492
Closed -$255K – 1187
2018
Q3 		$255K Buy
+1,492
New +$251K 0.01% 980
2018
Q1 		– Sell
-800
Closed -$67K – 1184
2017
Q4 		$67K Buy
+800
New +$66.7K ﹤0.01% 992

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors's LOXO Position: Q4 2018 in Review

Pacer Advisors sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 1,492 shares — an estimated $255K sold.

Pacer Advisors first reported a position in LOXO in Q4 2017 and held it in 2 quarters. The position peaked at $255K in Q3 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Pacer Advisors reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Pacer Advisors sold 1,492 Loxo Oncology, Inc shares in Q4 2018, an estimated $255K.
  • Pacer Advisors first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 2 quarters.
  • Pacer Advisors's Loxo Oncology, Inc position peaked at $255K in Q3 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Pacer Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.